Black Diamond Therapeutics (BDTX)
(Real Time Quote from BATS)
$2.53 USD
-0.01 (-0.39%)
Updated Feb 5, 2025 12:06 PM ET
3-Hold of 5 3
D Value B Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 3/11/25 |
---|---|
Current Quarter | -0.31 |
EPS Last Quarter | -0.28 |
Last EPS Surprise | 24.32% |
ABR | 1.14 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.30 |
Next Year | -1.22 |
EPS (TTM) | -1.33 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.31 | -0.31 | -1.30 | -1.22 |
# of Estimates | 7 | 5 | 7 | 7 |
Most Recent Consensus | -0.31 | -0.21 | -1.29 | -0.82 |
High Estimate | -0.25 | -0.20 | -1.24 | -0.82 |
Low Estimate | -0.36 | -0.44 | -1.34 | -1.93 |
Year ago EPS | -0.34 | -0.35 | -1.88 | -1.30 |
Year over Year Growth Est. | 8.82% | 11.43% | 30.85% | 5.93% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.31 | -0.31 | -1.30 | -1.22 |
7 Days Ago | -0.31 | -0.31 | -1.30 | -1.22 |
30 Days Ago | -0.31 | -0.31 | -1.30 | -1.22 |
60 Days Ago | -0.31 | -0.31 | -1.30 | -1.22 |
90 Days Ago | -0.31 | -0.31 | -1.30 | -1.22 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.31 | -0.31 | -1.30 | -1.22 |
Zacks Consensus Estimate | -0.31 | -0.31 | -1.30 | -1.22 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.28 | -0.36 | -0.35 | -0.34 | NA |
Estimate | -0.37 | -0.39 | -0.44 | -0.47 | NA |
Difference | 0.09 | 0.03 | 0.09 | 0.13 | 0.09 |
Surprise | 24.32% | 7.69% | 20.45% | 27.66% | 20.03% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more